Celldex Therapeutics, Inc.
CLDX- Exchange
- Nasdaq
- Industry
- In Vitro & In Vivo Diagnostic Substances
- SEC CIK
- 0000744218
No open-market purchases or sales by Celldex Therapeutics, Inc. insiders were filed in the last 90 days; 253 institutions reported holding it in 13F filings for Q2 2026, worth $3.16B in total; no superinvestor holds it.
Q2 2022 vs. Q1 2022
How the institutions holding Celldex Therapeutics, Inc. changed between Q1 2022 and Q2 2022.
All holders in Q2 2022All holders in Q1 2022
| Measure | Q1 2022 | Of which not filed for Q2 2022 | Q2 2022 | Change |
|---|---|---|---|---|
| Holders | 169 | 3 | 158 | −8 |
| Shares | 49.4M | 47.9K | 48.0M | −1.38M (−2.8%) |
| Value | $1.69B | $1.63M | $1.30B | −$388.0M (−23.0%) |
3 institutions that held it in Q1 2022 haven't filed for Q2 2022 yet. Not filing isn't selling, so the changes leave them out.
New holders (19)
Institutions that held Celldex Therapeutics, Inc. at the end of Q2 2022 but not at the end of Q1 2022.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Bellevue Group AG | 925,000 | $24.9M | 0.35% |
| Cormorant Asset Management, LP | 200,000 | $5.39M | 0.42% |
| Casdin Capital, LLC | 165,000 | $4.45M | 0.38% |
| BVF Inc | 154,000 | $4.15M | 0.20% |
| Norges Bank | 92,900 | $2.50M | 0.00% |
| Squarepoint Ops LLC | 78,345 | $2.11M | 0.02% |
| Sofinnova Investments, Inc. | 48,304 | $1.30M | 0.12% |
| Alps Advisors Inc | 27,740 | $748.0K | 0.01% |
| Marshall Wace, LLP | 20,023 | $539.0K | 0.00% |
| Mirae Asset Global Investments Co., Ltd. | 13,749 | $371.0K | 0.00% |
| Bayesian Capital Management, LP | 12,500 | $337.0K | 0.06% |
| Winton Group Ltd | 8,322 | $224.0K | 0.01% |
| Quadrant Capital Group LLC | 132 | $4.00K | 0.00% |
| The PNC Financial Services Group, Inc. | 100 | $3.00K | 0.00% |
| Truvestments Capital LLC | 73 | $2.00K | 0.00% |
| Parallel Advisors, LLC | 22 | $1.00K | 0.00% |
| Rockefeller Capital Management L.P. | 37 | $1.00K | 0.00% |
| Venture Visionary Partners LLC | 10 | $269 | 0.00% |
| CoreCap Advisors, LLC | 16 | $0 | 0.00% |
Sold out (27)
Institutions that held Celldex Therapeutics, Inc. at the end of Q1 2022 and filed for Q2 2022 without it.
Not filed for Q2 2022 yet (3)
Institutions that held Celldex Therapeutics, Inc. at the end of Q1 2022 and haven't filed a 13F for Q2 2022. Not filing isn't selling, so they aren't counted as sold out.
| Institution | Shares, Q1 2022 | Value, Q1 2022 |
|---|---|---|
| Teachers Retirement System of the State of Kentucky | 32,242 | $1.10M |
| Parametric Portfolio Associates LLC | 8,568 | $292.0K |
| Amalgamated Financial Corp. | 7,080 | $241.0K |